ACCESS Newswire
15 Jun 2021, 03:01 GMT+10
Announces Regulatory and Compliance Advisory Board
DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2021 / Pharma-Bio Serv, Inc. ('Pharma-Bio Serv' or the 'Company') (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced revenues for the three and six months ended April 30, 2021 were $5,042,000 and $9,530,000, respectively, a decrease of approximately $606,000 and $731,000, respectively, when compared to the same periods last year.
Net income for the three and six months ended April 30, 2021 was approximately $240,000 and $508,000, a decrease of approximately $448,000 and $706,000 when compared to the same periods last year, respectively. The decrease in net income is mainly attributable to the completion of projects in the Puerto Rico market during the three and six months ended April 30, 2020. The Company is actively pursuing higher margin business and has already taken significant steps to reduce administrative expenses to mitigate margin pressure.
'During the last two quarters we have seen significant business development in Europe and LATAM, which we expect will continue through the end of the year. We are also excited with new opportunities arising in the domestic market, which we expect will result in new projects in the short term,' said Victor Sanchez, CEO of Pharma-Bio Serv, Inc.
'To support our strategy of being recognized as a world-class provider of regulatory and compliance solutions, we have assembled a Regulatory and Compliance Advisory Board composed of former FDA officials and ex-industry members (biographical information regarding our Advisory Board can be found on our website at www.pharmabioserv.com). The Advisory Board members have strong relationships within the FDA and the Industry and will provide extremely valuable insights to the Company's management. We also believe that their relationships and knowledge will help attract new clients and business opportunities, providing additional growth opportunities and allowing us to continue to provide best in class regulatory and compliance solutions. ' continued Mr. Sanchez.
About Pharma-Bio Serv, Inc.
Pharma-Bio Serv services the Puerto Rico, United States, Europe and Latin America markets. Pharma-Bio Serv's core business is FDA and international agencies regulatory compliance consulting related services. The Company's global team includes leading engineering and life science professionals, quality assurance managers and directors.
Forward-Looking Statements
This news release contains 'forward-looking statements' within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of Pharma-Bio Serv. Forward-looking statements are based on the expectations, estimates, or projections of management as of the date of this earnings announcement. Although Pharma-Bio Serv's management believes these expectations, estimates, or projections to be reasonable as of the date of this earnings announcement, forward-looking statements are inherently subject to significant business risks, economic uncertainties, and competitive uncertainties, and other factors, which could cause its actual results or performance to differ materially from what may be expressed or implied in the forward-looking statements. Important factors that could cause Pharma-Bio Serv's actual results or performance to differ materially from the forward-looking statements include those set forth in the 'Risk Factors' section of Pharma-Bio Serv's Annual Report on Form 10-K for the year ended October 31, 2020, and in its other filings with the Securities and Exchange Commission, which filings are available on www.sec.gov. Pharma-Bio Serv disclaims any intention or obligation to update or revise any forward-looking statements to reflect subsequent events and circumstances, except to the extent required by applicable law.
Company Contact:
Pedro J. Lasanta
Chief Financial Officer
787 278 2709
SOURCE: Pharma-Bio Serv, Inc.
Get a daily dose of Boston Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Boston Star.
More InformationOTTAWA, Canada: With Canada Post struggling to maintain operations amid labour unrest, rivals like FedEx and UPS are stepping in to...
NEW YORK, New York - U.S. and global markets showed a mixed performance in Tuesday's trading session, with some indices edging higher...
PARIS, France: French military and intelligence officials have accused China of orchestrating a covert campaign to damage the reputation...
NEW DELHI, India: Birkenstock is stepping up its efforts to protect its iconic sandals in India, as local legal representatives conducted...
HONG KONG: China has fired back at the European Union in an escalating trade dispute by imposing new restrictions on medical device...
NEW YORK, New York - Monday's trading session saw mixed performances across U.S. and global markets, with several major indices posting...
FRANKLIN, Tennessee: Hundreds of thousands of Nissan and Infiniti vehicles are being recalled across the United States due to a potential...
(Photo credit: David Butler II-Imagn Images) Brayan Bello pitched a complete game and struck out 10 to help the Boston Red Sox extend...
(Photo credit: Wendell Cruz-Imagn Images) Washington and Kelly Olynyk barely got to know one another, as the Wizards dealt the newly...
(Photo credit: Kiyoshi Mio-Imagn Images) Washington Nationals catcher Keibert Ruiz returned to the seven-day concussion list Tuesday...
(Photo credit: Jesse Johnson-Imagn Images) Caitlin Clark and Napheesa Collier were encouraged to negotiate some trades immediately...
(Photo credit: Darren Yamashita-Imagn Images) Caitlin Clark plans to play for the Indiana Fever for the first time in more than two...